NYSEAMERICAN:CPHIChina Pharma Stock Price, Forecast & News

$0.41

-0.01 (-2.38 %)

(As of 04/9/2020 06:00 AM ET)

Add

Compare

Today's Range

$0.39

Now: $0.41▼

$0.45

50-Day Range N/A

52-Week Range

$0.21

Now: $0.41▼

$1.40

Volume1.12 million shs

Average Volume3.82 million shs

Market Capitalization$17.88 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for China Pharma.

3.4 Community Rank

Outperform Votes
China Pharma has received 175 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
China Pharma has received 86 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
China Pharma has received 67.05% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about China Pharma and other stocks. Vote “Outperform” if you believe CPHI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CPHI will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
China Pharma does not currently pay a dividend.
Dividend Growth
China Pharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, China Pharma insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

0.68 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN

Industry Drug Manufacturers - Major

Sub-IndustryN/A

SectorMedical

Current SymbolNYSEAMERICAN:CPHI

Previous SymbolNYSEMKT:CPHI

CUSIPN/A

CIKN/A

Webhttp://www.chinapharmaholdings.com/

Phone8689866811730

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees240

Outstanding Shares43,580,000

Market Cap$17.88 million

Next Earnings Date5/20/2020 (Estimated)

OptionableNot Optionable

Receive CPHI News and Ratings via Email

Sign-up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter.

China Pharma (NYSEAMERICAN:CPHI) Frequently Asked Questions

When is China Pharma's next earnings date?

China Pharma is scheduled to release its next quarterly earnings announcement on Wednesday, May 20th 2020. View our earnings forecast for China Pharma.

How were China Pharma's earnings last quarter?

China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) announced its earnings results on Wednesday, August, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $3.17 million during the quarter. View China Pharma's earnings history.

Has China Pharma been receiving favorable news coverage?

News coverage about CPHI stock has been trending very negative recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. China Pharma earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutChina Pharma.

Are investors shorting China Pharma?

China Pharma saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 624,500 shares, an increase of 174.0% from the February 27th total of 227,900 shares. Based on an average daily volume of 3,580,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 2.9% of the company's stock are sold short. View China Pharma's Current Options Chain.

Who are some of China Pharma's key competitors?

Some companies that are related to China Pharma include Allergy Therapeutics (AGY), NanoViricides (NNVC), Recce Pharmaceuticals (RCE), Pharmaxis (PXS), Vita Life Sciences (VLS), Futura Medical (FUM), Avivagen (VIV), Patrys (PAB), Antisense Therapeutics (ANP), Sareum (SAR), Cathay International (CTI), N4 Pharma (N4P), Bayer (BAYN), HedgePath Pharmaceuticals (MAYNF) and OTSUKA HOLDINGS/ADR (OTSKY).

What other stocks do shareholders of China Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include NovaBay Pharmaceuticals (NBY), Inovio Pharmaceuticals (INO), Novavax (NVAX), Biocept (BIOC), AbbVie (ABBV), Ibio (IBIO), Agile Therapeutics (AGRX), Cronos Group (CRON), Tonix Pharmaceuticals (TNXP) and VBI Vaccines (VBIV).

Who are China Pharma's key executives?

China Pharma's management team includes the following people:

Ms. Zhilin Li, Pres, CEO, Chairman & Interim CFO (Age 66)

What is China Pharma's stock symbol?

China Pharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CPHI."

How do I buy shares of China Pharma?

Shares of CPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is China Pharma's stock price today?

One share of CPHI stock can currently be purchased for approximately $0.41.

How big of a company is China Pharma?

China Pharma has a market capitalization of $17.88 million. China Pharma employs 240 workers across the globe. View additional information about China Pharma.

What is China Pharma's official website?

The official website for China Pharma is http://www.chinapharmaholdings.com/.

How can I contact China Pharma?

China Pharma's mailing address is 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU, HAN 570216, China. The company can be reached via phone at 8689866811730.

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Featured Article: Understanding the different types of bonds